You are viewing the site in preview mode

Skip to main content

Table 2 The Comparison of fat quality intake in two groups of normal and overweight or obese

From: The correlation between dietary fat quality indices and lipid profile with Atherogenic index of plasma in obese and non-obese volunteers: a cross-sectional descriptive-analytic case-control study

Variable Normal weight (n = 71) Overweight/Obese (n = 86) P-Value
Mean ± SD Median Mode Range Mean ± SD Median Mode Range
AIa 228.19 ± 28.32 226.3 203.04 197.02–260.21 461.48 ± 52.81 456.93 469.12 408.08–519.01 0.012*
TIa 471.15 ± 46.14 474.64 456.09 436.78–522.66 484.45 ± 50.63 474.64 465.96 431.96–537.84 0.841
hHa 71.85 ± 3.78 69.21 70.43 66.86–75.64 49.94 ± 4.13 50.69 49.97 43.35–55.14 0.034*
CSIa 30.40 ± 0.45 30.03 30.64 29.88–31.22 31.00 ± 0.93 31.10 30.94 30.07–32.33 0.824
Total fat 90.30 ± 35.51 89.11 74.07 55.09–126.98 95.52 ± 42.73 96.78 97.01 52.49–137.24 0.412
∑SFA 19.55 ± 8.01 20.03 18.93 11.04–27.68 22.01 ± 10.40 21.54 21.82 11.76–32.47 0.066
Loric acid (c12:0) 0.40 ± 0.27 0.39 0.43 0.12–0.68 0.41 ± 0.27 0.40 0.45 0.13–0.71 0.715
Myristic acid (14:0) 1.43 ± 0.87 1.32 1.50 0.57–2.30 1.56 ± 0.88 1.62 2.02 0.67–2.48 0.325
Palmitic acid (16:0) 8.43 ± 3.64 8.41 9.93 4.80–12.02 9.34 ± 4.67 9.35 8.28 4.72–14.01 0.875
Stearic acid (18:0) 4.00 ± 1.78 4.14 3.94 2.21–5.78 4.42 ± 2.41 4.52 4.78 2.01–6.71 0.062
∑MUFA 23.99 ± 11.38 24.41 22.86 12.04–35.18 21.97 ± 8.61 22.11 22.29 13.34–30.57 0.207
Oleic acid (18:1) 15.55 ± 8.43 15.98 14.07 7.33–19.42 13.38 ± 6.10 13.47 11.55 7.28–19.46 0.812
Palmitoleic acid (16:1) 0.79 ± 0.63 0.72 0.70 0.17–1.43 0.69 ± 0.43 0.68 0.93 0.24–1.15 0.209
∑PUFA 19.25 ± 12.20 21.22 15.03 7.20–30.03 22.45 ± 12.72 21.57 19.31 8.95–33.94 0.920
Linoleic acid (18:2n6) 1.22 ± 1.34 1.25 0.73 0.14–2.57 1.45 ± 1.24 1.59 1.08 0.20–2.69 0.267
C18.2.CLAs 0.41 ± 0.72 0.31 0.36 0.29–1.15 0.23 ± 0.32 0.28 0.21 0.09–0.58 0.144
Linolenic acid (18:3n6) 0.12 ± 0.14 0.09 0.13 0.03–0.30 0.17 ± 0.13 0.11 0.16 0.05–0.33 0.177
Linolenic acid (18:3n3) 0.41 ± 0.27 0.45 0.38 0.12–0.70 0.52 ± 0.27 0.49 0.56 0.24–0.79 0.565
Dihomo-linolenic acid (20:3n6) 0.34 ± 1.45 0.31 0.26 0.10–1.88 0.42 ± 1.23 0.45 0.37 0.08–1.79 0.129
Arachidonic acid (20:4n6) 0.11 ± 0.10 0.09 0.07 0.01–0.23 0.18 ± 0.08 0.19 0.16 0.08–0.29 0.212
Eicosapentaenoic acid (20:5n3) EPA 0.04 ± 0.05 0.03 0.02 0.01–0.11 0.03 ± 0.04 0.02 0.02 0.01–0.08 0.615
Docosahexaenoic acid (22:6n3) DHA 0.13 ± 0.12 0.11 0.05 0.01–0.26 0.12 ± 0.11 0.10 0.08 0.01–0.25 0.779
ω-6/ω-3 ratio 4.27 ± 0.29 4.25 4.50 3.98–4.59 4.60 ± 0.27 4.61 4.52 4.32–4.89 0.004**
Cholesterol 224.36 ± 112.73 228.65 201.12 110.14–332.38 250.89 ± 174.34 254.08 247.36 87.12–413.97 0.250
Total trans 4.39 ± 10.81 3.21 3.89 3.13–15.29 5.58 ± 10.27 3.98 4.27 3.51–10.09 0.481
  1. a Variables were compared using t independent test, rest of the variables were compared using Mann–Whitney U test. * Stands for P < 0.05. ** Stands for P < 0.01. Abbreviation: AI Atherogenicity index; TI Thrombogenicity index; H/H Σhypocholesterolemic/Σ Hypercholesterolemic ratio; CSI Cholesterol-Saturated Fat Index; ω-6/ω-3 Σ of Omega 6 series/Σ of Omega 3 series; SFAs saturated fatty acids; MUFAs monounsaturated fatty acids; PUFAs polyunsaturated fatty acids; ω6 omega 6 fatty acid (Linoleic acid); ω3 omega 3 fatty acid (Linolenic acid); P < 0.05 was considered to be significant